Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
During Phase III, the drug or treatment is administered under expanded, controlled and uncontrolled conditions in trials of 1,000-3,000 or more persons. They are conducted only "after preliminary evidence suggesting effectiveness of the drug has been obtained" (Understanding clinical trials, 2006, NIH). These studies conduct cost or risk-benefit analysis of taking the drug and compare the benefits of the drug or treatment to existing options (Understanding clinical trials, 2006, NIH). A drug may be effective, but its side effects may be far more severe than current treatments, and if it provides no additional benefit than existing treatments, the drug may not be approved. Information is also collected to determine when the drug is safe to use, and under what conditions. For example, certain drugs such as MAOIs cannot be taken with other drugs or eaten with certain foods without causing severe health problems; some sedating medications should not be taken when the user will be driving within a few hours.
At the final phase, Phase IV, "studies are done after the drug or treatment has been marketed to gather information...
These trials are conducted after the drug has been released to the public, given that possible side effects and reactions may only be spotted after individuals have been taking the drugs for long periods of time. Additionally, the continued efficacy of the drug should be monitored, as some drugs may produce short-term benefits but sharply decrease in efficacy, with increased user tolerance.
References
What are clinical trial phases? (2006, October 11). FAQ: Clinical Trials. National Institute of Health (NIH). Retrieved November 17, 2001 at http://www.nlm.nih.gov/services/ctphases.html
What is a clinical trial? (2006, October 11). FAQ: Clinical Trials. National Institute of Health
(NIH). Retrieved November 17, 2001 at http://www.nlm.nih.gov/services/ctclintrial.html
Understanding clinical trials. (2006). National Institute of Health (NIH). Retrieved November
17, 2001 at http://clinicaltrials.gov/ct2/info/understand#Q19
Clinical Psychology Dissertation - Dream Content as a Therapeutic Approach: Ego Gratification vs. Repressed Feelings An Abstract of a Dissertation Dream Content as a Therapeutic Approach: Ego Gratification vs. Repressed Feelings This study sets out to determine how dreams can be used in a therapeutic environment to discuss feelings from a dream, and how the therapist should engage the patient to discuss them to reveal the relevance of those feelings, in their present,
Clinical Trial Management Systems Though all four systems of Clinical Data Management (CDM) seem to possess identical functionality, it appears that Perceptive Informatics is more useful, as it requires complex IT infrastructure for its functioning. CDM represents a crucial clinical research phase that generates superior, statistically sound, and reliable information from the clinical trial phase. This aids in drastically reducing the timespan between drug development and marketing stages. Clinical trial intends
Clinical Research Process Advances in Research The Common Fund programs of the National Institutes of Health (NIH) include the PROMIS (Patient-Reported Outcomes Measurement Information System) initiative (NIH, 2013). The PROMIS initiative seeks to exploit the creative potential of researchers and clinicians, for the purpose of developing new methods for reporting patient outcomes; however, in contrast to more quantitative measures, such as laboratory tests and radiological findings, the PROMIS initiative is focused on
Outsourcing Firms outsourcing clinical research for a number of different reasons. The theory of comparative advantage underlies CRO, as firms in other countries might be able to do the research more effectively, or more efficiently. Often, CRO done in order to save money, as is particularly the case with India. In other instances, the outsourcing is done to firms that have developed particular specialties in research (Piachaud, 2002). In India, firms are
Recruitment Increasing Level Participation Clinical Trials Delays completion a clinical trial typically caused lack patient availability. In fact, studies 10% eligible patients participate clinical trials. Recruitment: Methods and challenges One of the most common recruitment strategies when soliciting individuals to participate in experiments is offering financial compensation through general advertisements on the web, radio, or in other publications. Financial compensation encourages individuals to participate in clinical trials and other types of research studies
Bio-Statistics Research activities, whether clinical trial based, experimentally designed, or product oriented, must exhibit and command interest, enthusiasm, and passionate commitment. To this end the researcher must catch the essential quality of the excitement of discovery that comes from research well done. The first step in the attainment of the desired research goal is to develop a scientific approach toward that which is being investigated. A requirement within the scientific